Related by context. All words. (Click for frequent words.) 54 infliximab monotherapy 53 CITIZENS FINANCIAL SERVICES INC. 53 CONSOLIDATED SUBSIDIARIES CONDENSED CONSOLIDATED 53 CALIFORNIA COASTAL COMMUNITIES INC. 53 prednisone prednisolone plus 53 SUBSIDIARIES BUSINESS SEGMENT 53 AMOUNTS IN THOUSANDS EXCEPT 53 #,# NOVA MEASURING 53 ROLLINS INC. AND SUBSIDIARIES 52 © Jihad Unspun 52 OF FINANCIAL CONDITION 52 FINANCIAL RESULTS RECONCILIATION OF 51 NINE MONTHS ENDED SEPTEMBER 51 # -GT2 RS 51 DATA unaudited 50 FINANCIAL AND OPERATIONAL 50 + PH# 50 PER SHARE AMOUNTS 50 Merckx Hinault Miguel Indurain 50 Pooled Analysis 50 OF OPERATIONS AND COMPREHENSIVE 50 STATEMENTS OF OPERATIONS UNAUDITED 50 GearUpForSports makes 50 PIONEER DRILLING COMPANY 50 OF OPERATIONS THREE MONTHS 50 Randomized Trials 50 Prevalence Worldwide 50 AND SUBSIDIARIES 50 -#.# pp [002] 50 SUMMARY OF RESULTS 50 SUBSIDIARIES Condensed Consolidated Statements 50 AND COMPREHENSIVE INCOME Unaudited 49 Unaudited Unaudited Unaudited Audited 49 #:#-#,# CrossRef Medline [002] 49 INC. UNAUDITED CONDENSED CONSOLIDATED 49 INCOME UNAUDITED 49 J Pediatr 49 Prolongs Survival 49 UNAUDITED Amounts 49 CONDENSED STATEMENT OF OPERATIONS 49 Arch Neurol 49 PRO FORMA RESULTS 49 Twelve Twelve Months 49 INC. SELECTED FINANCIAL DATA 49 plus prednisone 49 OF EARNINGS Unaudited 49 3rd Qtr 2nd Qtr 49 Zometa hazard 49 Munghana Lonene Listenership 49 -Przybyl 49 Pro Forma Adjusted 49 CrossRef Medline 49 Controlled Trial 49 AND SUBSIDIARIES Condensed Consolidated 49 GAAP TO ADJUSTED 48 angioplasties stents 48 Study Analyzes 48 SUBSIDIARIES Consolidated Statements 48 MarketAxess Announces 48 ITS SUBSIDIARIES CONDENSED CONSOLIDATED 48 Pastoral Psychological 48 THREE MONTHS ENDED DECEMBER 48 Ended Twelve Months Ended 48 OF SEPTEMBER 48 Qtr Qtr Qtr Qtr 48 #.#.# [037] 48 #:#-#,# [002] 48 HERTZ GLOBAL HOLDINGS INC. 48 STATEMENTS OF 48 TWELVE MONTHS ENDED DECEMBER 48 STATEMENTS OF EARNINGS 48 Unconsolidated GAAP 48 Adjust Non GAAP 48 patients coinfected 48 Theological Responses 48 UNAUDITED THREE MONTHS ENDED 48 Pt Chg 48 YEAR ENDED DECEMBER 48 irinotecan cisplatin 48 HIGHLIGHTS UNAUDITED 48 Quarters Ended Six Months 48 SELECTED RATIOS 48 COMPARATIVE FIGURES Certain 48 GAAP ments 48 SUBSIDIARIES Consolidated Statement 48 SUBSIDIARIES UNAUDITED CONSOLIDATED STATEMENTS 48 OF EARNINGS UNAUDITED 48 Cancer Incidence Mortality 48 -AL Gustin 47 CONSOLIDATED STATEMENT OF INCOME 47 AND COMPREHENSIVE INCOME 47 - RevGreencool 47 OPERATING RESULTS 47 MANAGEMENT DISCUSSION AND ANALYSIS 47 SUBSIDIARIES Condensed Consolidated 47 Acrylic Resins 47 - Babelgum Online 47 QUARTERS ENDED 47 Randomized Phase II 47 2nd Qtr 1st Qtr 47 Six Months Six Months 47 GAAP Adj 47 Three Months Months Ended 47 STATEMENT OF OPERATIONS 47 Lipper Large Cap 47 EOG RESOURCES INC. 47 - Unaudited [013] 47 Unaudited Fourth Quarter 47 SUBSIDIARIES 47 -firewall router 47 Quarters Ended Nine Months 47 OPERATIONS Amounts 47 - Revenues [006] 47 Stent Placement 47 cytogenetic analyzes 47 DISCOVERY HOLDING COMPANY 47 Meta Analysis 47 Per Per 47 Shopping.com Shopzilla 47 GAAP FINANCIAL MEASURES 47 PRO FORMA 47 FOREXYARD Daily Forex 46 Intravenous Equipment 46 Percent Percent 46 QUARTER TO DATE 46 coatings lubricants 46 Predecessor Successor 46 Randomized Controlled Trials 46 - UnaudCrouppen 46 UNAUDITED Three Months 46 STATEMENTS OF FINANCIAL POSITION 46 unaudited - 46 Third Quarter Ended Nine 46 SYNERGY Stent 46 #:#-# [033] 46 AND OTHER COMPREHENSIVE INCOME 46 Visualization Equipment 46 ARCALYST ® 46 TO NON GAAP MEASURES 46 pegylated interferons 46 STATEMENTS OF EARNINGS Unaudited 46 MONTHS ENDED 46 4th Qtr 3rd Qtr 46 SUBSIDIARIES Consolidated Balance Sheets 46 Stat finder Check 46 Sequential Quarter 46 Transparent Conductive 46 HealthGrades analyzed 46 Unaudited Third Quarter 46 CONDENSED CONSOLIDATED INCOME STATEMENTS 46 Fourth Quarter Twelve Months 46 GAAP FINANCIAL INFORMATION 46 Factors Impacting 46 AND FUNDS FROM 46 Hematological Cancers 46 -Hua Tian 46 Prolongs Life 45 Unfav 45 Audited Unaudited 45 Currency Majors Technical 45 OPERATING HIGHLIGHTS 45 Months Months 45 Six Months Months 45 Ultrasensitive 45 OPERATIONS UNAUDITED 45 FINANCIAL CONDITION AND 45 She admired Ayumu 45 = Per [007] 45 EOG RESOURCES INC. SUMMARY 45 improperly prescribing painkillers 45 RECORD1 45 Psychiatry #:#-# [002] 45 CONSOLIDATED STATEMENT OF 45 Unaudited Twelve Months 45 DCT INDUSTRIAL TRUST INC. 45 Quarters Ended Years 45 Orders Backlog 45 Systematic Review 45 Univariate 45 WESTWOOD ONE INC. SUPPLEMENTAL 45 -dwayne tingley 45 ® bortezomib 45 Team 4X EagleEye 45 plus COPEGUS 45 Broadspire segment 45 Functional Outcomes 45 1GB ATI Mobility 45 Adjusted Diluted EPS 45 ODYSSEY HEALTHCARE INC. AND 45 EARNINGS SUMMARY 45 Change - [011] 45 SEISMIC Trial 45 Chelating Agents 45 SELECTED FINANCIAL AND 45 CONSOLIDATED RESULTS 45 Nine Months Nine Months 44 Highlights Three Months 44 Fourth Quarter Ended Twelve 44 J Rheumatol 44 YEAR TO DATE 44 STATISTICS Unaudited 44 GLOSSARY OF TERMS 44 Month Period Ended 44 Prospective Randomized Trial 44 CEDC discusses 44 -ABGL 44 -Kahaani Ghar Ghar Ki 44 Quarter Ended #/#/# #/#/# [002] 44 BUSINESS DESCRIPTION 44 Bone Metastases 44 Adjustment Non GAAP 44 -Raghavendra Rathore 44 Comparative Figures 44 Ultrasound Equipment 44 PERCENT CHANGE 44 vincristine adriamycin 44 unaudited audited 44 Oral Anticoagulants 44 unaudited Nine Months 44 BROOKLINE BANCORP INC. AND 44 AND SUBSIDIARIES Consolidated Statements 44 Supplementary Data 44 TRICO MARINE SERVICES INC. 44 Consolidated Condensed Statement 44 Multicenter Phase 44 plus dacarbazine 44 NON GAAP RECONCILIATION 44 royalty pooled 44 Provides Detailed 44 2nd edn 44 Per Share Quarter Ended 44 Unaudited Condensed Consolidated 44 COFI calculation 44 #:#-# [019] 44 COMPANY CONSOLIDATED INCOME STATEMENTS 44 Fibre Channel SONET SDH 44 Anesthesia Disposables 44 GAAP NON GAAP 44 STATEMENTS OF CONSOLIDATED INCOME 44 mimicked saliva 44 -0 Content Outline 44 Carotid Endarterectomy 44 Test Methodology 44 ALIMTA cisplatin 44 Diego Forlan Atletico Madrid 43 Three Months Twelve Months 43 ScD MPH 43 #:#-# [023] 43 J Immunol 43 anthracycline taxane 43 Clinical Evaluation 43 Uganda Ethiopia Eritrea 43 noninterest expense divided 43 Tumor Response 43 US shah despised 43 Myocardial Perfusion 43 CONSOLIDATED BALANCE SHEET UNAUDITED 43 operatingincome 43 OTHER OPERATIONS 43 unaudited unaudited 43 REIT Taxable 43 IBERIABANK CORPORATION CONDENSED CONSOLIDATED 43 Second Quarter Six Months 43 Fab Wafer 43 Appalachian hovel 43 Summary Balance Sheet 43 Apnea Monitors 43 Adjusted EBITDAX 43 Prognostic Factors 43 BALANCE SHEETS Unaudited 43 virus HBV infection 43 Prognostic Value 43 INC. Supplemental 43 EBITDA Calculation 43 CT Angiography 43 -SEAMUS BRENNAN 43 OSI Pharmaceuticals Tarceva 43 Highly anomalous 43 - unaudited [008] 43 NPS PHARMACEUTICALS INC. AND 43 Industrial Protective Clothing 43 Qtr Ended 43 FINANCIAL INFORMATION UNAUDITED 43 Clinical Outcome 43 Change - [003] 43 dacarbazine chemotherapy 43 =America Airline Satisfaction 43 Unaudited Quarter Ended 43 2nd Qtr '# 42 Richardson Tom Tresh 42 doi #.# 42 # -loudly protested 42 massive sulphide ores 42 ABAs thus far 42 transarterial chemoembolization 42 nondeposit fees 42 Psychiatric Epidemiology 42 Quarter Quarter Ended 42 dacarbazine 42 NOI FFO 42 REAL ESTATE BUSINESS 42 Six Months Ended -Ronald Moten 42 #Q# #Q# Change [001] 42 cyclophosphamide doxorubicin vincristine 42 ACE inhibitors beta blockers 42 Year Ended Ended 42 FINANCIAL RESULTS 42 Third Quarter Nine Months 42 interferon alfa 2b 42 J Virol 42 unaudited unaudited unaudited 42 Incr 42 UNAUDITED CONSOLIDATED BALANCE SHEETS 42 Double Blind Randomized 42 Balance Sheet Cash Flow 42 Sheets Unaudited 42 Original HP LaserJet 42 Jimmie Foxx Lou Gehrig 42 Operative mortality 42 Competitive Positioning 42 NSABP B 42 GULF RESOURCES INC. AND 42 sector correlation seasonality 42 Competitive Scenario 42 Randomized Clinical Trials 42 SELECTED INCOME STATEMENT DATA 42 Imaging Techniques 42 Three Month Periods 42 microbiological eradication 42 unaudited unaudited -watchdog BaFin 42 FOLFOX4 42 corresponding reconciliations 42 Kronos TiO2 production 42 Cancer Epidemiol Biomarkers Prev 42 -hip shakin 42 Pro Forma Net 42 XIENCE V PROMUS Stent 42 #.#/BOE [002] 42 Wood Preservative Chemicals 42 FTE headcount Three Months 41 Topics Covered Executive 41 Romar Crenshaw 41 YTD YTD 41 OF INCOME unaudited 41 multicenter multinational 41 Temperature Monitoring Devices 41 Markets Analyse 41 Postdoctoral Position 41 Long Lesion 41 RMB RMB 41 SUMMARY TABLE 41 STEALTH C 41 -Coco Reef 41 Therapeutic Efficacy 41 Pharmacokinetic parameters 41 surpassed Ken Margerum 41 Tumor Cell 41 NON GAAP FINANCIAL INFORMATION 41 - Aarkstore Enterprise [002] 41 Uterine Cancer 41 cerebral somatic oximeter 41 Meta analyzes 41 Moody Aa2 41 Historical Pro Forma 41 Taxus Stent 41 tabular amounts 41 LIST OF FIGURES 41 POLYCOM INC. GAAP 41 Benchmarking Analysis 41 Certain comparative 41 Quarter Ended Quarter Ended 41 Time Charter Equivalent 41 Restruc 41 Reconciliation Tables 41 ADCS CGIC 41 TMC TMCnet 41 Content Outline 41 Period Ended 41 Clinical Implications 41 Crisil Composite 41 Unaudited Dollars 41 AND SUBSIDIARIES Segment 41 Q#/# Q#/# [001] 41 -prosumer 41 include microparticles liposomes 41 measuring #.#mm x [002] 41 Angiographic 41 Microplate Readers 41 Modulates 41 # -b Reflects 41 '#s except 41 STATEMENTS OF OPERATIONS 41 Dry Powder Inhalers 41 Epithelial Cell 41 FINANCIAL SUMMARY 41 standard meanings prescribed 41 -Keops 41 FINANCIAL MEASURES 41 Q# Q# Q# 40 Endometrial Cancer 40 SUMMARY RESULTS 40 oral diclofenac 40 -Andrea Seabrook 40 Invasive Fungal Infections 40 Unaudited Unaudited 40 Sentinel Lymph Node Biopsy 40 -Edna Hibel 40 Dose Ranging 40 Various Types 40 Brain Function 40 Three Months Nine Months 40 Mauritius Namibia 40 Q#/FY# 40 J Clin Oncol 40 Quarter Ended Nine Months 40 Change - [002] 40 INCOME STATEMENT 40 TO FUNDS FROM 40 Gender Differences 40 MARINER ENERGY 40 Leverage ratios 40 RT Ponting capt 40 Q3 YTD 40 Iloilo Bacolod 40 Six Months Ended 40 DXY gauge 40 Comparative 40 Gastric Cancer 40 SEGMENT INFORMATION 40 GATT accord 40 Comparative Analysis 40 Managed Balance Sheet 40 FAD variously defined 40 Times Herald.com does 40 German Purity Laws 40 SPY Imaging System 40 Fourth Quarter Ended 40 OPERATING AND 40 Condensed Cash Flow 40 was#.# 40 Ended - [011] 40 -6News Jennifer 40 = [044] 40 Ecological Synthesis 40 Antitumor 40 Multicenter Study 40 Postmenopausal Hormone Therapy 40 DG FastChannel delivers 40 Ended -Agility SAP 40 Antihypertensive 40 Three Months Six Months 40 Diagnostic Criteria 40 SPECfp 40 DNA Microarrays 40 conducted retrospective cohort 40 FINANCIAL INFORMATION 40 unaudited Three Months 40 #:#-# [006] 40 2ND QUARTER #:# 40 1st Qtr 2nd Qtr 40 Selected Operating 40 SOUTHWEST BANCORP INC. 40 • Compounded singles 40 AND PRO FORMA 39 Geochimica et Cosmochimica Acta 39 Taxable equivalent 39 GLOBOCAN 39 Ringside punch 39 Illegally obtaining 39 Ecumen derived 39 RMB RMB USD 39 Twelve Months Ending 39 Sleep Apnea Diagnostic 39 -T#/T# 39 Behavioral Neurobiology 39 Signaling Pathways 39 Financial Ratios 39 Protein Biomarker 39 Dose Response 39 EndedDecember 39 -Tomine 39 CALGB 39 GameRankings.com average 39 Three Months Ending 39 -Name Directory DND 39 multivariable Cox 39 NAEP math 39 Provides textual analysis 39 haematologic 39 Breast Carcinoma 39 RESULTS OF OPERATIONS 39 III #Table 39 pharmacodynamic parameters 39 Pro Forma Results 39 Recent Past 39 Placebo Controlled Trial 39 Veterinary Vaccines 39 comparedto 39 X ray angiography 39 Constant Currency 39 Hematological 39 ended -David Gozal 39 melphalan prednisone 39 Condensed Income 39 Comparison Tool 39 Selected Balance Sheet 39 #.#/BOE [001] 39 Analytical Methods 39 Analytical Tool 39 - Unaudited [015] 39 Tjeerdema chairs 39 #:#-# [022] 39 #:#-# [031] 39 Mathematics Teaching 39 colorectal lung 39 workhorse lesions 39 HUMAN SCIENCES INC. Condensed 39 GAAP Measures 39 assign Outlooks 39 separation airspeed 39 Homefurnishing Retail industry 39 Clinical Practice Guideline 39 Aspergillus nidulans 39 #:#-# [029] 39 Adjusted Non GAAP 39 Industrial Enzymes 39 Seasonal Pattern 39 FY#E EV EBITDA 39 Cancer Res 38 average assets ROAA 38 average equity ROAE 38 #:#-# [018] 38 Factors Influencing 38 Vitro Activity 38 Percentage Change 38 GBPm 38 UNITED MICROELECTRONICS CORPORATION 38 unevaluated properties 38 antiangiogenic activity 38 Unaudited Pro Forma 38 Industrial Conglomerates industry 38 Racial Attitudes 38 morbidity mortality persistency 38 BPG pouch machinery 38 compute FFO 38 Correlates 38 Tabular amounts 38 Taxotere chemotherapy 38 highest tertile 38 Sexual Satisfaction 38 unaudited -Nesha Starcevic 38 Och Ziff Funds 38 Clinical Significance 38 Segmented Results 38 UNAUDITED 38 & Consumable Fuels 38 intact parathyroid hormone 38 Year Ended 38 SSNOI 38 Tweet Sentiments web 38 Infectious Disease Testing 38 Gamesense match 38 Unaudited -immanent 38 Bosnia Herzegovina Macedonia 38 Comparative Study 38 #Q# #Q# Var 38 legalizing incest 38 Inflammatory Pain 38 Sherri Muzher 38 Mechanistic 38 HRH Prince Zeid Ra'ad 38 DOI #.# 38 Non GAAP Disclosures 38 DKKm 38 -Lighting Designers 38 Bioequivalence 38 -Soft soled shoes 38 EXECUTIVE SUMMARY 38 Unaudited Consolidated 38 -sodium chloride 38 Thymosin Beta 4 38 READER ADVISORY 38 Superdelegates swelled 38 #/#.# [013] 38 chemically synthesized pills 38 -ANDREA SACHS 38 Clinical Decision Making 38 comparedwith 38 Gateway GT# 38 Protein Expression 38 Psychological Assessment 38 MERIT ES 38 HER2 homodimer levels 38 Animal Feed Additives 38 Bioavailability 38 3rd edn 37 Pharmacodynamic 37 Radiation Induced 37 strategies KPIs metrics 37 PIB PET 37 Susceptibility Testing 37 NORTHERN TRUST CORPORATION Supplemental 37 3rd Qtr 4th Qtr 37 - ASSETS [014] 37 Mathematical Statistics 37 intercepts approximate 37 receiving highly emetogenic 37 Oilfield Chemicals 37 Phthalic anhydride 37 Neuroanatomy 37 Alloying 37 anthracycline containing 37 capillary arrays 37 adjusted unlevered free 37 similarly titled measures 37 SUMMARY DATA SHEET 37 Molecular Genetic 37 Diagnosis Treatment 37 Secondary endpoints include 37 antiretroviral naïve 37 cardiac perfusion 37 Adverse Event 37 Epidemiological Survey 37 SuperMedia specializes 37 prescriber surveys 37 unaudited Amounts 37 NCSLT #-# 37 oral Hycamtin 37 FUND Consolidated Statements 37 mean ± SEM 37 -Edgewater Networks 37 Antiangiogenic 37 Inception Date 37 Computations 37 Wheat Starch 37 clinicopathological features 37 Disclaimer Past performance 37 HIGHLIGHTS Three Months 37 medically inoperable 37 symptomatic carotid stenosis 37 -0 Key 37 Pharmacoeconomic 37 animal xenograft models 37 NCES #-# 37 #:#-# [037] 37 Data Extraction 37 similarly titled captions 37 Three Months Ended Twelve 37 CFS BANCORP INC. 37 IMPACT DCM 37 Attack Trial ALLHAT 37 Feed Acidifiers 37 #:#-# [014] 37 FINANCIAL STATEMENTS 37 Westinghouse TX #F#S 37 Comparison 37 Darbepoetin Alfa 37 #:#-# [016] 37 Nine Months 37 oral clodronate 37 Cost Effectiveness 37 # -DiBacco 37 clinico pathological 37 oncologic outcomes 36 Analytical Method 36 category medians 36 Comparative Condensed Consolidated Statements 36 Observational Studies 36 Specialty Phosphates 36 retrospective observational study 36 FFR guided 36 Three Months EndedDecember 36 postoperative chemotherapy 36 Protein Synthesis 36 TAXUS Element Stent 36 DAS# remission 36 CEDC calculation 36 FOLFOX regimen 36 Histopathological 36 Automotive Sensors 36 qualitative parameters 36 sustained virological response 36 unaudited Quarter Ended 36 #.#c #.#c [002] 36 - -Rough Sleepers 36 CYPHER R stent 36 unaudited Consolidated Statements 36 EBITDA Adjusted EBITDA 36 follicular lymphoma FL 36 Jovan Witherspoon 36 Currency Translation 36 Non IFRS 36 Quantity kg 36 Unaudited Unaudited Audited 36 multivariate statistical 36 Psychodynamic 36 Cervical Spine 36 Variance Analysis 36 carboplatin paclitaxel 36 achieve sustained virologic 36 pin LQFP packages 36 MetaCritic.com 36 Adversely Affects 36 Overview #.#.# [002] 36 intravesical therapy 36 Teratology 36 TNF blocker therapy 36 Foreign Currency Translation 36 Supplemental Non GAAP 36 Satellite Transponders 36 Adrian Guelke professor 36 SME Direkt poll 36 MINDRAY MEDICAL INTERNATIONAL LIMITED 36 BizAcumen LLC 36 Months Ended -Oracle #g databases 36 -gangplanks 36 racecards form 36 Operations Unaudited 36 Unaudited Amounts 36 Contents Introduction 36 IFRS IFRS 36 OSIs 36 #:#-# [027] 36 Multivariable 36 Stonemor Partners NASDAQ STON 36 Protein Structures 36 Recent Accounting Pronouncements 36 Consolidated Cash Flows 36 Cash Flow Statement 36 heavily outjabbed Hopkins 36 Molecular Mechanisms 36 coronary interventional 36 -Kaloki 36 Multivariate logistic regression 36 Novel Therapeutic 35 #Table [003] 35 Three Months Ended Nine 35 intersegment eliminations 35 #-#/# [022] 35 retrospectively analyzed 35 Predisposition 35 Fourth Qtr 35 Therapeutic Monoclonal Antibodies 35 Echocardiographic 35 Reported Adjustments Non GAAP 35 Transcriptome 35 carboplatin chemotherapy 35 radiotherapy RT 35 Reche Caldwell Jabar Gaffney 35 Nonclinical 35 Immunogenicity 35 Lecturer Senior Lecturer 35 Cancer Incidence 35 Statistical Summary 35 nonvertebral 35 Sciencein 35 paclitaxel eluting stents 35 Gendering 35 Genetically Engineered Animals 35 CHRIS CASSAR 35 Toxicological 35 Beds Powered 35 Multicenter 35 Intervention Trial 35 Chris Landsea meteorologist 35 -Lake Andrusia 35 Summary Table 35 -FALL CAMP 35 #.#L/# km [001] 35 univariate 35 SS NOI 35 Pinpoint Demographics 35 PSA kinetics 35 biochemical recurrence 35 TAXUS Express 35 SMITHFIELD FOODS INC. AND 35 Hepatocellular Carcinoma 35 Anatomical Models 35 Comparable EBITDA 35 LIST OF TABLES Table 35 Pathophysiology 35 -Elmers 35 endoscopic remission 35 TAXUS Liberte Atom Stent 35 metastatic RCC 35 Supplemental Schedule 35 -Tyrell Fenroy 35 PartnerRe Ltd. Supplementary 35 Retained Earnings Unaudited 35 operates TJ Maxx 35 GBPm GBPm GBPm 35 Unaudited Thirteen 35 microarray gene expression 35 #.#x #.#x [002] 35 legally producible under 35 Doctoral Fellow 35 MINNESOTA VIKINGS Agreed 35 Nucleic Acid Amplification 35 exclude nonrecurring items 35 Operations unaudited 35 Biochemical Sciences 35 Statistical Supplement Operating 35 multifamily delinquency 35 Count Basie Woody 35 Ringside punching 35 multimedia duplication replication 35 Seriously Flawed 35 Pawn Lending 35 YE# [002] 35 EARNINGS Taxable equivalent 34 multiple logistic regression 34 Musculoskeletal Disorders 34 Celanese delivers 34 prime RMBS 34 locoregional recurrence 34 Quarter Ended 34 locoregional 34 calculate DSO uses 34 Coronary CTA 34 persistency mortality 34 Tables reconciling 34 Operations Unaudited Dollars 34 S. pombe 34 -#.# [005] 34 quantitative coronary angiography 34 Operational Metrics 34 AAA sovereigns 34 rituximab refractory 34 EDWARDS LIFESCIENCES CORPORATION 34 Pharmacokinetic 34 * Reclassified 34 Ingenix manipulated 34 Developmental Genetics 34 Dtsch Arztebl Int 34 Income Unaudited Amounts 34 expenses associated therewith 34 Three Months Ended 34 Highlights Unaudited 34 dose dexamethasone 34 = [026] 34 #S rRNA 34 methylmalonic acid 34 SPECint rate# 34 GAAP Fully Diluted 34 Attitudes Towards 34 -Quarriers 34 demonstrated clinically meaningful 34 Mutagenesis 34 Not Meaningful 34 bearing vertically emplaced 34 -Restart 34 Contained Metal 34 Los Chorros recover 34 Trace Element 34 Randomised 34 Pharmacogenetics 34 Yr Yr 34 Computational Genomics 34 called elastography distinguished 34 Socioeconomic Status 34 Omnitarg 34 Adjusted EBIT 34 rewriteable DVD 34 Grocery Retailing 34 SF #v# 34 Predictive Toxicology 34 compared 34 ROAE 34 Fitch BBB medians 34 Quality Indicators 34 Descriptive statistics 34 surveys Herbenick 34 SUMMARY OF QUARTERLY RESULTS 34 Preoperative 34 Comparable 34 recurrent GBM 34 Serology 34 Seasonally Adjusted 34 Toxicological Sciences 34 Efficiency CAFE 34 similarly configured 34 Unaudited 34 Bacteriological 34 Selected Quarterly 34 System FARS 34 Analyte 34 Ethical Considerations 34 Protein Interactions 34 #,#,# dwt 34 National Inpatient Sample 33 Molecular Epidemiology 33 Mineral Resource estimation 33 lung prostate 33 Assessment Questionnaire 33 Cognitive Functioning 33 Geography Geology 33 city/#.# highway 33 horizontal CBM 33 COMMERCE BANCSHARES INC. 33 -Amneal Pharmaceuticals LLC 33 Overviews 33 extensive gravure printing 33 Interventional Cardiology Devices 33 Unaudited Reconciliation 33 Modifiable 33 null responder 33 nosebleeds headache 33 Multivariate Analysis 33 Comparator 33 Efficacy 33 LT#u 33 BBB medians 33 recompletions reactivations development 33 RT qPCR 33 Cognitive Abilities 33 USGAAP 33 tables summarize 33 Highest Quarterly 33 logistic regression analyzes 33 Logistic Regression 33 unfavorable variances 33 No. #R Consolidation 33 AA medians 33 Critical Perspectives 33 http:/www.jdpower.com/corporate 33 arebased 33 omnium combines 33 = [028] 33 Histologic 33 Comparability 33 sensitivity specificity 33 Exousia Evergreen 33 ABCSG 33 comparable 33 subthreshold depression 33 calculate FFO 33 Significant assay 33 Randomized trials 33 Survey MEPS 33 p.# [001] 33 Ownership Pattern 33 Coal lignite coal 33 CyberDefender expectation 33 vinorelbine 33 testwork carried 33 Adjusted 33 RevPAR ADR 33 Companion Diagnostics 33 DLQI 33 Carreker Corporation improves 33 pp #-# 33 microbiologically evaluable 33 Relapsing Remitting MS RRMS 33 Captiva cribs 33 immunohistochemical 33 decreased 33 unresectable 32 - -SIRTI 32 Realised Earnings 32 Biobehavioral 32 iron ore manganese ore 32 RAD SVT 32 Macroscopic 32 Rank # 32 BITRE 32 bendamustine 32 city/# highway 32 Pharmacokinetics 32 Segment Operating 32 multiple linear regression 32 Debt Ratios 32 EGFR mutation positive 32 Histopathologic 32 standardized meanings prescribed 32 GROUP RESULTS 32 NovoTTF 32 EpiCeram TM 32 facilitates comparisons 32 Spending Patterns 32 calculating TCE 32 Competitive Landscape 32 Critical Thinking Skills 32 Phase #/#a trial 32 Mathematical Models 32 ANCOVA 32 Pro forma 32 obliterated Hiroshima 32 Lesotho Namibia 32 pCR 32 WOMAC scores 32 OPEB obligation 32 Outpacing 32 Segmental 32 supplement reconciles 32 Regulatory Developments 32 Harry Houdini Emma 32 Highly Selective 32 Pro Forma Non GAAP 32 Psychobiology